The 7th Executive Committee Meeting will be held next autumn to discuss about the progress since the last meeting and to plan the next activities.
The 6th Executive Committee Meeting took place on 15th March 2019 to discuss about the progress since the last meeting and to plan the next activities.
This meeting gathered all MIROCALS partners for presenting the progress made since the launch of the project a year ago as well as the next achievements for the coming year.
The last consortium meeting of MIROCALS was held on June 7th and 8th 2018 in Milan to present the progress made since the beginning of the project.
The MIROCALS consortium is delighted to announce that the first participant has been recruited to the MIROCALS trial, at Hospices Civils de Lyon, France.
The MIROCALS (Modifying Immune Response and Outcomes in ALS) Clinical Trial is still on-going, with recruitment continuing until the end of September 2019.
Read moreClinical trials are expensive to run and with several more neurology clinics taking part, ...
Read moreAs with everything else affected by Brexit, there are probably more questions than answers!
Read more
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 633413.